These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 25155598)
1. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription. Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598 [TBL] [Abstract][Full Text] [Related]
2. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9. Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357 [TBL] [Abstract][Full Text] [Related]
3. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934 [TBL] [Abstract][Full Text] [Related]
4. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration. Charles S; Ammosova T; Cardenas J; Foster A; Rotimi J; Jerebtsova M; Ayodeji AA; Niu X; Ray PE; Gordeuk VR; Kashanchi F; Nekhai S J Cell Physiol; 2009 Nov; 221(2):469-79. PubMed ID: 19626680 [TBL] [Abstract][Full Text] [Related]
5. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90. Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154 [TBL] [Abstract][Full Text] [Related]
7. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9. Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582 [TBL] [Abstract][Full Text] [Related]
8. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription. Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467 [TBL] [Abstract][Full Text] [Related]
9. Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals. Lin X; Ammosova T; Kumari N; Nekhai S Curr Pharm Des; 2017; 23(28):4122-4132. PubMed ID: 28677499 [TBL] [Abstract][Full Text] [Related]
11. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies. Rice AP Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507 [TBL] [Abstract][Full Text] [Related]
12. Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner. Khan SZ; Mitra D J Biol Chem; 2011 Jul; 286(26):22943-54. PubMed ID: 21555514 [TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function. Ramakrishnan R; Liu H; Donahue H; Malovannaya A; Qin J; Rice AP Retrovirology; 2012 Oct; 9():90. PubMed ID: 23110726 [TBL] [Abstract][Full Text] [Related]
15. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616 [TBL] [Abstract][Full Text] [Related]
16. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition. Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435 [TBL] [Abstract][Full Text] [Related]
17. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb. Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990 [TBL] [Abstract][Full Text] [Related]
18. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649 [TBL] [Abstract][Full Text] [Related]
19. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression. Fujinaga K; Irwin D; Geyer M; Peterlin BM J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330 [TBL] [Abstract][Full Text] [Related]
20. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Fong YW; Zhou Q Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]